Search Results - C. Frank Bennett

C. Frank Bennett

Bennett in 2018 C. Frank Bennett is an American pharmacologist. Bennett is currently the Senior Vice President of Research and Neurology Franchise Leader at Ionis Pharmaceuticals. He is a 2019 Breakthrough Prize winner in Life Sciences, which he shared with his collaborator Adrian R. Krainer for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative disease spinal muscular atrophy. Provided by Wikipedia
  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor by Juergen Scharner, Sabrina Qi, Frank Rigo, C. Frank Bennett, Adrian R. Krainer

    Published 2019
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    GOLGA8 increases bulk antisense oligonucleotide uptake and activity in mammalian cells by Moira A. McMahon, Meghdad Rahdar, Swagatam Mukhopadhyay, Huynh-Hoa Bui, Christopher Hart, Sagar Damle, Margo Courtney, Michael W. Baughn, Don W. Cleveland, C. Frank Bennett

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice by Dominic Jauvin, Jessina Chrétien, Sanjay K. Pandey, Laurie Martineau, Lucille Revillod, Guillaume Bassez, Aline Lachon, A. Robert McLeod, Geneviève Gourdon, Thurman M. Wheeler, Charles A. Thornton, C. Frank Bennett, Jack Puymirat

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: